50th Annual Clinical Diabetes and Endocrinology

Discuss implications of recent large clinical trials in the care of patients with type 2 diabetes including the evidence related to prevention of microvascular disease and macrovascular disease Explain the relative roles of declining beta-cell function versus insulin resistance in type 2 diabetes and how this might inform clinical management Outline the approach to individualizing osteoporosis therapy including which patients would benefit from therapy, and explain the pros and cons of osteoporosis medications Understand lipid management guidelines and new therapeutic directions Describe important differences between adults and youth with type 2 diabetes Summarize the evidence regarding effects of obesity and diabetes on cognitive dysfunction Recognize the contribution of genetics and epigenetic changes on risk for obesity Apply the revised ATA thyroid nodules/cancer guidelines, and understand new methods for risk stratification of individuals with thyroid nodules and/or thyroid cancer Discuss the key issues related to optimal management of maternal hypothyroidism Explain the evidence for glycemic control in the inpatient setting, and apply a systematic approach to management Recognize potential long-term effects of childhood cancer treatment on the endocrine system including hypopituitarism, bone loss, obesity, and metabolic syndrome Identify when to suspect and how to screen for anabolic steroids, and discuss anabolic therapy in chronic disease Define adrenal insufficiency in the ICU setting